BNRBurning Rock Biotech Ltd

Nasdaq brbiotech.com


$ 4.67 $ -0.05 (-1.03 %)    

Thursday, 05-Sep-2024 15:16:51 EDT
QQQ $ 459.86 $ 0.43 (0.09 %)
DIA $ 407.95 $ -1.96 (-0.48 %)
SPY $ 548.56 $ -1.34 (-0.24 %)
TLT $ 99.56 $ 0.56 (0.57 %)
GLD $ 232.35 $ 1.92 (0.83 %)
$ 4.7012
$ 4.67
-- x --
-- x --
$ 4.67 - $ 4.67
$ 4.52 - $ 13.20
13,946
na
48.49M
$ 2.76
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 bayer-and-burning-rock-collaborate-to-boost-patient-access-to-precision-cancer-medicines-in-china

 Burning Rock Biotech Limited (NASDAQ:BNR, the ", Company", or ", Burning Rock", )))) has recently announced a ...

 burning-rock-biotech-to-adjust-ads-to-ordinary-share-ratio-effective-may-15

BNR will change the ratio of its American depositary shares (the "ADSs") to Class A ordinary shares from one (1) ADS re...

 burning-rock-biotech-q4-eps-022-up-from-031-yoy-sales-1710m-down-from-2062m-yoy

Burning Rock Biotech (NASDAQ:BNR) reported quarterly losses of $(0.22) per share. This is a 29.03 percent increase over losses ...

 earnings-scheduled-for-november-30-2023

Companies Reporting Before The Bell • 111 (NASDAQ:YI) is projected to report earnings for its third quarter. • Frontline (NYS...

 burning-rock-biotech-q3-eps-023-up-from-031-yoy-sales-1748m-down-from-2174m-yoy

Burning Rock Biotech (NASDAQ:BNR) reported quarterly losses of $(0.23) per share. This is a 25.81 percent increase over losses ...

 burning-rock-and-boehringer-ingelheim-inked-a-master-service-agreement-in-oncology-companion-diagnostics

Burning Rock Biotech Limited (NASDAQ:BNR, the ", Company", or ", Burning Rock", )))) is pleased to announce tha...

 stocks-that-hit-52-week-lows-on-friday

  Friday's session saw 225 companies set new 52-week lows.

 burning-rock-biotech-q2-eps-018-up-from-037-yoy-sales-2017m-up-from-1953m-yoy

Burning Rock Biotech (NASDAQ:BNR) reported quarterly losses of $(0.18) per share. This is a 51.35 percent increase over losses ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION